Search clinical trials for: MiniMed™ 780G Insulin Pump system

Total 82 results

Medtronic Diabetes

Recruiting

In-Home Study With MiniMed™ 780G Pump Automated Control in Type 2-Evaluation of the AHCL System in Adults With Insulin-requiring Type 2 Diabetes

Type 2 Diabetes Treated With Insulin

United States
Medtronic Diabetes

Completed

The MiniMed™ 780G Glycemic Control and Quality of Life Study for the Treatment of Pediatric and Adult Subjects With Type 1 Diabetes in France.

Type 1 Diabetes

France
Steno Diabetes Center Copenhagen

Completed

The Steno 780G Study

Type 1 Diabetes

Denmark
Medtronic Diabetes

Completed

Evaluation of Meal Gesture Dosing in Adults With Type 1 Diabetes

Type 1 Diabetes

Israel
Medtronic Diabetes
Eli Lilly and Company

Completed

Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adults and Pediatrics Utilizing Lyumjev®

Type 1 Diabetes

United States
Sheba Medical Center

Recruiting

Advanced Hybrid Closed Loop System (AHCL) in Older Patients With Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 1

Israel
Medtronic Diabetes

Completed

Study Comparing Effectiveness of Intraperitoneal Insulin Administration to Subcutaneous Insulin Administration (MIP310)

Type 1 Diabetes

United States
Medtronic Diabetes

Active, not recruiting

Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®

Type 1 Diabetes

United States, Canada, Australia
Jagiellonian University
Medtronic

Enrolling by invitation

Transition of T1DM Patients Aged Over 65 Years Into AHCL (780G) Insulin Pump (780G65+)

Diabetes Type 1

Poland
Steno Diabetes Center Copenhagen
Rigshospitalet, Denmark

Recruiting

Next Generation Advanced Insulin Delivery System in Adults With Diabetes and Advanced Renal Disease

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Hemodialysis | Peritoneal Dialysis | Chronic Kidney Disease | Dialysis

Denmark
University Hospital, Grenoble

Completed

Study of Insulin Pump in Prevention of Low Glucose Events in Adults With Type 1 Diabetes at Risk of Severe Hypoglycemia (ALPPHY)

Diabetes, Type 1

France
Jagiellonian University
Medtronic Poland Spółka z ograniczoną odpowiedzialnością; University of Rzeszow

Unknown

AHCL System Initiation in T1D Patients naïve to Technology

Diabetes Mellitus, Type 1
Helsinki University Central Hospital
Medtronic International Trading Sarl

Recruiting

Glycemic Outcomes and Safety With Minimed 780G System in Children With Type 1 Diabetes Aged 2-6 Years

Type 1 Diabetes

Finland
Seoul National University Hospital
Medtronic

Recruiting

Effects of AHCL Insulin Pump on Glycemic Control and Psychosocial Outcomes in Pediatric Patients With Type 1 Diabetes

Type 1 Diabetes

Korea, Republic of
Medtronic Diabetes

Completed

Obtain a Good Blood Glucose Control With the Paradigm Real Time System (RTD)

Type 1 Diabetes

France
Kinderkrankenhaus auf der Bult

Completed

Comparison of Two Management Systems in Patients With Type 1 Diabetes (Pediatric SmartHome)

Drug Therapy | Patient Care

Germany
Fundacion para la Investigacion Biomedica del Hospital...

Completed

Clinical Trial to Evaluate the Efficacy of the Smart Insulin Pen Compared to a Closed Loop System in Patients With Type 1 Diabetes (EBIACE-1) (EBIACE-1)

Type1diabetes

Spain
Medtronic Diabetes

Completed

OpT2mise Glucose Control in Type 2 Diabetes Mellitus (DM) With Insulin Pump Therapy (OpT2mise)

Diabetes Mellitus, Type 2

United States, France, Germany, Austria, Canada, Hungary, Israel, Italy, Macedonia, The Former Yugoslav Republic of, Netherlands, Serbia, South Africa, Spain
ELIAS Emergency University Hospital

Recruiting

Evaluating the Efficacy and Quality of Life Impact of Transitioning to Advanced Hybrid Closed-Loop Insulin Pump Therapy in Romanian Children With Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 1

Romania
Steen Andersen
Medtronic

Completed

Effect of CSII and CGM on Progression of Late Diabetic Complications

Type 1 Diabetes Mellitus

Denmark
Sidra Medical and Research Center

Completed

An 8-Day Initiation of Advanced Hybrid Closed Loop System In Children and Adolescents

Type 1 Diabetes

Qatar
Hamad Medical Corporation
Sidra Medicine

Unknown

Hybrid Closed Loop System for Patients on Multiple Daily Insulin Injections

Type 1 Diabetes

Qatar
Medtronic Diabetes

Completed

Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data

Diabetes

United States
Medtronic Diabetes

Completed

In Clinic Evaluation of the PLGM Feature (PLGM)

Type 1 Diabetes

United States
Sidra Medical and Research Center

Completed

Evaluation of Minimed 670G in T1D Patients on Multiple Daily Injection

Diabetes Mellitus, Type 1

Qatar
Medtronic Diabetes

Completed

User Evaluation of the MiniMed 620G and 640G Insulin Pumps

Type 1 Diabetes | Type 2 Diabetes

United Kingdom, Denmark, Australia, Spain
Medtronic Diabetes

Recruiting

Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System and Control at Home

Type 1 Diabetes

United States, Spain, New Zealand, Canada, France, Germany, Italy, Sweden, United Kingdom
Medtronic Diabetes

Completed

Assess the Efficacy of the Low Glucose Suspend (LGS) Feature in the MiniMed Paradigm® X54 System

Type 1 Diabetes Mellitus

United States
Medtronic Diabetes

Completed

User Evaluation of the MiniMed 640G Insulin Pump

Type 1 Diabetes | Type 2 Diabetes

United Kingdom, Australia
Kinderkrankenhaus auf der Bult

Completed

Use of an Automated Insulin Delivery System Compared to Sensor Augmented Pump at Patients With Type 1 Diabetes (T1D) (DREAM5)

Type 1 Diabetes

Germany
Medtronic Diabetes

Completed

Feasibility Study for Training Pump Naïve Subjects To Use The Paradigm® System And Evaluate Effectiveness (STAR2)

Type 1 Diabetes

United States
Medtronic Diabetes

Completed

MiniMed™ 670G System China Study for Type I Diabetic

Diabetes Mellitus, Type 1

China
University of Ljubljana, Faculty of Medicine

Completed

Prevention of Hypoglycaemia With Predictive Insulin Suspend Using Sensor Augmented Insulin Pump in Children (SportGuard)

Type 1 Diabetes Mellitus

Slovenia, Israel
Medtronic Diabetes

Completed

SWITCH - Sensing With Insulin Pump Therapy to Control HbA1c (SWITCH)

Diabetes Mellitus, Type 1

Netherlands, Slovenia, Denmark, Austria, Italy, Luxembourg, Spain
Amsterdam UMC, location VUmc
Eli Lilly and Company

Completed

The Effects of RT-CGM on Glycemia and QoL in Patients With T1DM and IHA (INCONTROL)

Type 1 Diabetes Mellitus | Hypoglycemia Unawareness

Netherlands
Chinese PLA General Hospital

Completed

Effect Insulin Pump Therapy to Patients With Diabetic Nephropathy

Insulin Pump Therapy in Treating Diabetic Nephropathy
Johns Hopkins Bloomberg School of Public Health
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Continuous Glucose Monitoring and Insulin Pump Therapy in Diabetic Gastroparesis (GLUMIT-DG)

Diabetic Gastroparesis

United States
Tammy Moore

Active, not recruiting

Testing the Effectiveness of a Falls Prevention System

High Risk for Falling

United States
Institut de Recherches Cliniques de Montreal
Juvenile Diabetes Research Foundation

Withdrawn

Closed-loop Control of Postprandial Glucose Levels in Children and Adults With Type 1 Diabetes

Type 1 Diabetes

Canada
Medtronic Corporate Technologies and New Ventures

Completed

Safety and Efficacy Study to Compare Continuous Infusion of Interferon With Standard of Care for Chronic Hepatitis C (COPE-HCV)

Hepatitis C

United States
Medtronic Diabetes

Completed

Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature (ASPIRE)

Type 1 Diabetes

United States
University of Alabama at Birmingham

Completed

Fast Track CSII Using a Novel Device in Young Children With Newly Diagnosed T1DM

Type 1 Diabetes Mellitus

United States
Medtronic Diabetes

Completed

Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System

Type 1 Diabetes Mellitus

United States
Ypsomed AG
Diabetes Center Berne Research AG

Completed

YpsoPump Occlusion Detection Algorithm: Collection of Real-world Data for In-silico Evaluation of a New Software Algorithm to Refine Occlusion Detection in Subjects With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion

Diabetes Mellitus, Type 1

Germany, Switzerland
Medtronic Diabetes

Completed

Use of the Guardian™ Connect System With Smart Connected Devices

Type 1 Diabetes Mellitus

United States
Huazhong University of Science and Technology

Recruiting

Hybrid Closed-loop Insulin Delivery System in Perioperative Diabetic Patients: an Open-label, Randomized Controlled Trial

Diabetes Mellitus

China
King Fahad Medical City

Active, not recruiting

Closed Loop Pumps vs. Traditional Open Loop Pumps in Managing Blood Glucose Levels in T1DM Patients Fasting in Ramadan. (HybridRam)

Insulin Pump Therapy

Saudi Arabia
Sansum Diabetes Research Institute
Mayo Clinic; University of Padova; University of Virginia; Harvard University; University...

Completed

At Home Study of a Zone-Model Predictive Control (MPC) Controller and a Health Monitoring System (HMS) With the Diabetes Assistant (DiAs) System and Run-to-Run Adaptation

Type 1 Diabetes Mellitus

United States
Diabetes Care Center
Animas Corporation

Completed

Diabetes Mellitus Type 2 Basal Insulin Dosing Requirements Study

Type 2 Diabetes Mellitus

United States
Sansum Diabetes Research Institute
Mayo Clinic; University of Padova; University of Virginia; University of California...

Completed

Early Feasibility Study of Zone-MPC and HMS With DiAs in the Outpatient Setting

Diabetes Mellitus, Type 1

United States

Search clinical trials for: MiniMed™ 780G Insulin Pump system

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Singapore

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations